Cargando…

Imaging dopamine neurotransmission in Parkinson's disease: biomarker versus surrogate end point

Detalles Bibliográficos
Autor principal:	Innis, Robert B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2004
Materias:	Posters & Images in Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181804/ https://www.ncbi.nlm.nih.gov/pubmed/22034463

Ejemplares similares

Detection of dopamine neurotransmission in “real time”
por: Badgaiyan, Rajendra D.
Publicado: (2013)

Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission
por: Godar, Sean C., et al.
Publicado: (2014)

Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons
por: Ducrot, Charles, et al.
Publicado: (2023)

Dopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
por: Rizzi, Giorgio, et al.
Publicado: (2017)

Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?
por: Khlghatyan, Jivan, et al.
Publicado: (2018)

PET Imaging of Dopamine Neurotransmission During EEG Neurofeedback
por: Ros, Tomas, et al.
Publicado: (2021)

13. ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
por: Bloomfield, Michael
Publicado: (2018)

Use of Surrogate end points in HTA
por: Mangiapane, Sandra, et al.
Publicado: (2009)

The Effects of Exercise on Dopamine Neurotransmission in Parkinson’s Disease: Targeting Neuroplasticity to Modulate Basal Ganglia Circuitry
por: Petzinger, G.M., et al.
Publicado: (2015)

Debate: Are surrogate end-point studies worth the effort?
por: Valabhji, Jonathan, et al.
Publicado: (2000)

13.1 ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
por: Moreira, Fabricio
Publicado: (2018)

Dynamic control of the dopamine transporter in neurotransmission and homeostasis
por: Bu, Mengfei, et al.
Publicado: (2021)

Implications of GABAergic Neurotransmission in Alzheimer’s Disease
por: Li, Yanfang, et al.
Publicado: (2016)

Surrogate end points and their role in clinical trial
por: Jaykaran,
Publicado: (2009)

The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging
por: Bellucci, Arianna, et al.
Publicado: (2017)

Copper: from neurotransmission to neuroproteostasis
por: Opazo, Carlos M., et al.
Publicado: (2014)

MERCs. The Novel Assistant to Neurotransmission?
por: Shirokova, Olesya M., et al.
Publicado: (2020)

Targeted sensors for glutamatergic neurotransmission
por: Hao, Yuchen, et al.
Publicado: (2023)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease
por: Lhommée, Eugénie, et al.
Publicado: (2014)

Habitual behavior and dopamine cell vulnerability in Parkinson disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

Mixed neurotransmission in the hippocampal mossy fibers
por: Münster-Wandowski, Agnieszka, et al.
Publicado: (2013)

Activity dependent CAM cleavage and neurotransmission
por: Conant, Katherine, et al.
Publicado: (2015)

Glycine neurotransmission: Its role in development
por: Salceda, Rocío
Publicado: (2022)

Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
por: Kaasinen, Valtteri
Publicado: (2015)

The evolutionary origin of the need to sleep: an inevitable consequence of synaptic neurotransmission?
por: Cantor, Robert S.
Publicado: (2015)

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder
por: Cao, Ruihua, et al.
Publicado: (2020)

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging
por: Rodriguez, Manuel, et al.
Publicado: (2014)

Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
por: Hou, Lijuan, et al.
Publicado: (2017)

Developmental changes in human dopamine neurotransmission: cortical receptors and terminators
por: Rothmond, Debora A, et al.
Publicado: (2012)

Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain
por: Sinclair, Duncan, et al.
Publicado: (2014)

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
por: Sambo, Danielle O., et al.
Publicado: (2017)

Incubation of cocaine craving coincides with changes in dopamine terminal neurotransmission
por: Alonso, I. Pamela, et al.
Publicado: (2022)

Dysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity
por: Kishikawa, Yuki, et al.
Publicado: (2022)

Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter
por: Traktirov, Dmitrii S., et al.
Publicado: (2023)

Orexinergic neurotransmission in temperature responses to amphetamines
por: Molkov, Yaroslav I, et al.
Publicado: (2013)

Spontaneous purinergic neurotransmission in the mouse urinary bladder
por: Young, John S, et al.
Publicado: (2008)

A taste for ATP: neurotransmission in taste buds
por: Kinnamon, Sue C., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8opscvrnqfk8lh1m8o9ggr0o4m